• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认识胰岛素抵抗在多囊卵巢综合征中的作用:从以葡萄糖为中心的方法到以胰岛素为中心的模型的范式转变。

Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model.

作者信息

Parker Jim, Briden Lara, Gersh Felice L

机构信息

School of Medicine, University of Wollongong, Wollongong 2522, Australia.

Centre for Menstrual Cycle and Ovulation Research, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.

出版信息

J Clin Med. 2025 Jun 6;14(12):4021. doi: 10.3390/jcm14124021.

DOI:10.3390/jcm14124021
PMID:40565766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12194245/
Abstract

Polycystic ovary syndrome (PCOS) is a common metabolic-endocrine disorder affecting women of reproductive age, and insulin resistance (IR) is a key pathophysiological feature. Current medical education and clinical practice emphasize glucose-centric approaches in PCOS management, and IR testing is often overlooked due to limited emphasis in current clinical guidelines or the lack of standardized protocols. Additionally, the glucose-focused paradigm has been the standard of care for decades. However, this approach has led to delayed diagnosis of progressive metabolic and reproductive consequences, leaving many patients underdiagnosed and undertreated. Therefore, we propose a paradigm shift towards an insulin-centric model for PCOS management. This new approach aims to diagnose IR at an earlier stage, enabling the timely implementation of effective lifestyle and treatment strategies. By focusing on IR, clinicians can potentially limit the progression of PCOS-related reproductive and metabolic diseases. The insulin-centric model is a novel approach that involves comprehensive IR screening, dynamic insulin testing, personalized lifestyle and insulin-sensitizing interventions, and regular monitoring of insulin and glycemic parameters. This model could improve patient outcomes by facilitating early diagnosis of metabolic dysfunction and reducing the incidence of subsequent chronic disease. Furthermore, this model has broader implications, potentially transforming treatment approaches for various chronic diseases beyond PCOS.

摘要

多囊卵巢综合征(PCOS)是一种影响育龄女性的常见代谢 - 内分泌紊乱疾病,胰岛素抵抗(IR)是其关键的病理生理特征。当前的医学教育和临床实践在PCOS管理中强调以葡萄糖为中心的方法,由于当前临床指南中对此强调有限或缺乏标准化方案,IR检测常常被忽视。此外,以葡萄糖为重点的模式几十年来一直是治疗标准。然而,这种方法导致了对渐进性代谢和生殖后果的诊断延迟,使许多患者未得到充分诊断和治疗。因此,我们提议将PCOS管理模式转向以胰岛素为中心的模式。这种新方法旨在更早阶段诊断IR,从而能够及时实施有效的生活方式和治疗策略。通过关注IR,临床医生有可能限制PCOS相关生殖和代谢疾病的进展。以胰岛素为中心的模式是一种新颖的方法,包括全面的IR筛查、动态胰岛素检测、个性化的生活方式和胰岛素增敏干预措施,以及定期监测胰岛素和血糖参数。该模式可通过促进代谢功能障碍的早期诊断和降低后续慢性病的发病率来改善患者预后。此外,该模式具有更广泛的意义,可能会改变PCOS以外各种慢性病的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/a4ff9fcc2125/jcm-14-04021-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/9542839ffae7/jcm-14-04021-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/37c6fa267ed8/jcm-14-04021-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/68174dc50f0c/jcm-14-04021-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/a4ff9fcc2125/jcm-14-04021-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/9542839ffae7/jcm-14-04021-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/37c6fa267ed8/jcm-14-04021-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/68174dc50f0c/jcm-14-04021-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12194245/a4ff9fcc2125/jcm-14-04021-g004a.jpg

相似文献

1
Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model.认识胰岛素抵抗在多囊卵巢综合征中的作用:从以葡萄糖为中心的方法到以胰岛素为中心的模型的范式转变。
J Clin Med. 2025 Jun 6;14(12):4021. doi: 10.3390/jcm14124021.
2
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征中中度和重度抑郁及焦虑症状的高患病率:一项系统评价和荟萃分析。
Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044.
3
Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.多囊卵巢综合征中的胰岛素抵抗:正常血糖-高胰岛素钳夹研究的系统评价和荟萃分析
Hum Reprod. 2016 Nov;31(11):2619-2631. doi: 10.1093/humrep/dew243. Epub 2016 Oct 7.
4
The potential role of the Mediterranean diet for the treatment and management of polycystic ovary syndrome: a review of the pathophysiological mechanisms and clinical evidence.地中海饮食在多囊卵巢综合征治疗与管理中的潜在作用:病理生理机制及临床证据综述
Proc Nutr Soc. 2024 Nov 19:1-12. doi: 10.1017/S0029665124007584.
5
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
6
Evaluating serum anti-Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome in Pakistani women.评估血清抗苗勒管激素作为巴基斯坦女性多囊卵巢综合征诊断生物标志物的作用。
Int J Gynaecol Obstet. 2025 Jun 25. doi: 10.1002/ijgo.70240.
7
Mechanistic insight into nanomedicine for polycystic ovary syndrome.多囊卵巢综合征纳米药物的作用机制洞察
Mol Biol Rep. 2025 Jun 21;52(1):618. doi: 10.1007/s11033-025-10709-7.
8
Efficacy and safety of Chinese patent medicine Xiao Yao San in polycystic ovary syndrome: A systematic review and meta-analysis.中药逍遥散治疗多囊卵巢综合征的疗效和安全性:系统评价和荟萃分析。
J Ethnopharmacol. 2023 Sep 15;313:116517. doi: 10.1016/j.jep.2023.116517. Epub 2023 Apr 25.
9
Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.二甲双胍是否能改善非肥胖型多囊卵巢综合征不孕妇女的生殖结局?荟萃分析和系统评价。
Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:38-62. doi: 10.1016/j.ejogrb.2022.01.025. Epub 2022 Feb 1.
10
Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.辅助生殖技术周期中预防卵巢过度刺激综合征的干预措施:Cochrane系统评价概述
Cochrane Database Syst Rev. 2017 Jan 23;1(1):CD012103. doi: 10.1002/14651858.CD012103.pub2.

引用本文的文献

1
Metabolic Mediation of the Association Between Hyperandrogenism and Paratubal Cysts in Polycystic Ovary Syndrome: A Structural Equation Modeling Approach.多囊卵巢综合征中高雄激素血症与输卵管旁囊肿关联的代谢介导作用:一种结构方程模型方法
J Clin Med. 2025 Aug 6;14(15):5545. doi: 10.3390/jcm14155545.

本文引用的文献

1
Curcumin and its formulations for the treatment of polycystic ovary syndrome: current insights and future prospects.姜黄素及其制剂在多囊卵巢综合征治疗中的应用:当前见解与未来展望
J Ovarian Res. 2025 Apr 15;18(1):78. doi: 10.1186/s13048-025-01660-z.
2
Single-cell profiling of the human endometrium in polycystic ovary syndrome.多囊卵巢综合征患者子宫内膜的单细胞分析
Nat Med. 2025 Mar 20. doi: 10.1038/s41591-025-03592-z.
3
Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies.内分泌代谢综合征与代谢综合征:不同但相互关联的病症
Gynecol Obstet Invest. 2025 Mar 20:1-11. doi: 10.1159/000545280.
4
Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome.综合多组学分析揭示补体成分3是多囊卵巢综合征免疫失调的核心驱动因素。
Front Endocrinol (Lausanne). 2025 Mar 3;16:1523488. doi: 10.3389/fendo.2025.1523488. eCollection 2025.
5
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: an evolutionary metabolic adaptation.多囊卵巢综合征:起源与影响:多囊卵巢综合征:一种进化的代谢适应。
Reproduction. 2025 Mar 24;169(4). doi: 10.1530/REP-25-0021. Print 2025 Apr 1.
6
Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential.天然化合物在多囊卵巢综合征管理中的应用:激素调节与治疗潜力的全面综述
Front Nutr. 2025 Feb 11;12:1520695. doi: 10.3389/fnut.2025.1520695. eCollection 2025.
7
Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation.内分泌、代谢及炎症方面的多囊卵巢综合征病理生理学
J Ovarian Res. 2025 Feb 20;18(1):34. doi: 10.1186/s13048-025-01621-6.
8
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS.妊娠期糖尿病与多囊卵巢综合征:来自欧洲多囊卵巢综合征学会(EGOI-PCOS)的立场声明
Front Endocrinol (Lausanne). 2025 Jan 31;16:1501110. doi: 10.3389/fendo.2025.1501110. eCollection 2025.
9
Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes.二甲双胍在多囊卵巢综合征管理中的治疗作用更新:对病理生理过程和生育结局的影响
Womens Health (Lond). 2025 Jan-Dec;21:17455057241311759. doi: 10.1177/17455057241311759.
10
Efficacy of -Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis.N-乙酰半胱氨酸治疗多囊卵巢综合征的疗效:系统评价与荟萃分析。
Nutrients. 2025 Jan 14;17(2):284. doi: 10.3390/nu17020284.